Uniunea Europeană -
română -
EMA (European Medicines Agency)
lenalidomide mylan
mylan ireland limited - lenalidomidă - mielom multiplu - imunosupresoare - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
everolimus mylan 10 mg
synthon hispania sl - spania - everolimus - compr. - 10mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
everolimus mylan 2,5 mg
synthon hispania sl - spania - everolimus - compr. - 2,5mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
everolimus mylan 5 mg
synthon hispania sl - spania - everolimus - compr. - 5mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
everolimus mylan 10 mg
synthon hispania sl - spania - everolimus - compr. - 10mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
everolimus mylan 2,5 mg
synthon hispania sl - spania - everolimus - compr. - 2,5mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
everolimus mylan 5 mg
synthon hispania sl - spania - everolimus - compr. - 5mg - alte antineoplazice inhibitori de protein-kinaza
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
solifenacin mylan 10 mg
mylan hungary kft - ungaria - solifenacinum succinat - compr. film. - 10mg - alte preparate urologice (incl. antispastice) antispastice urinare
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
solifenacin mylan 5 mg
mylan hungary kft - ungaria - solifenacinum succinat - compr. film. - 5mg - alte preparate urologice (incl. antispastice) antispastice urinare
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
pramipexol mylan 0,26 mg
mylan hungary kft - ungaria - olanzapinum - compr. elib. prel. - 0,26mg - agenti dopaminergici agonisti dopaminergici